U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.
about
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaCirculating MicroRNAs as Biomarkers for SepsisRole of microRNAs in Alcohol-Induced Multi-Organ InjuryCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCNoncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCRData Normalization Strategies for MicroRNA Quantification.A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels.The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesisParasite-derived microRNAs in host serum as novel biomarkers of helminth infectionCirculating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness.Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.Persistently elevated osteopontin serum levels predict mortality in critically ill patients.Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients.Circulating microRNA Profiling Needs Further Refinement Before Clinical Use in Patients With Aortic Stenosis.MicroRNA expression profiles of serum from patients before and after chemotherapy.Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients.Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillationCirculating microRNAs as Potential Biomarkers of Infectious Disease.Post- harvest consideration factors for microRNA research in cellular, tissue, serum and plasma samples.A comprehensive method for identification of suitable reference genes in extracellular vesicles.The choice of endogenous controls in exosomal microRNA assessments from biofluids.Normalization matters: tracking the best strategy for sperm miRNA quantification.Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines.MicroRNA Expression Analysis of Centenarians and Rheumatoid Arthritis Patients Reveals a Common Expression Pattern.Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).The hunt for fatal myocardial infarction biomarkers: predictive circulating microRNAs.Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.Identification of Reference Genes for Analysis of microRNA Expression Patterns in Equine Chorioallantoic Membrane and Serum.Blood-based tumor biomarkers in lung cancer for detection and treatment.Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.Exploration of the R code-based mathematical model for PMI estimation using profiling of RNA degradation in rat brain tissue at different temperatures.Identification of a reference gene for the quantification of mRNA and miRNA expression during skin wound healing.Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels.microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients.Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment.Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria.
P2860
Q26765476-04377B93-6298-4E19-B276-28CB2DD6315AQ26772133-2BC91BBB-DCB2-4A56-B272-5FC055EE5AFBQ26776506-779F35DD-49CE-42C9-ABB2-B0ACB1855C1EQ28073562-785950FD-6541-4FAC-8BA8-213FC822B515Q30241331-E1804791-FB92-421E-8739-9A389443ACE8Q30984776-132616FD-46D3-432D-84C9-DA9CE82AE8A7Q30997590-434A27C8-9E04-46B5-911A-F094EF2CADEDQ33684834-85BF4AA5-4A81-43A6-8E8D-5A708E0F4027Q34512770-84E5F250-FA26-4992-AECE-B745F9E15F7EQ35055339-9C9C1C97-E88F-4FBC-9E18-FF905233B68CQ35109196-119CEDA7-4831-47AE-A04C-74663EA70379Q35163820-348345DA-C556-432C-8A09-6F6C47737889Q35690791-45EC2F4E-191D-4055-A0C8-4AD64E0EA8CDQ35814641-CDCCD34C-4D58-4BDD-B74B-4847219EFAD1Q35879526-B6987EAC-A879-4740-B102-939729B01EF3Q36141660-9EB7C41D-15B6-432D-9E6C-2FA8202F7D0AQ36332907-F060064B-7114-454D-AFA1-33E627660362Q37314018-EF230AA2-790A-4C59-9779-1D7661AD403EQ37404766-75525825-5F55-416C-B146-7F77E98C6A20Q37602019-08453644-20C8-49AE-8669-CAD9BEE75A10Q37643903-91129CC3-BF70-4FDD-A775-A774880FE58EQ38232818-64AD8BCC-3AA7-4E98-AAC4-86B41C233E47Q38621265-24F9C487-0FBA-4F24-985F-EF89EB256EACQ38903386-3F16B2F7-011B-4B06-8C6F-7F0AEB39D1E2Q39117925-06A1EAA1-58CF-40F9-9E47-216FBE8C2D9EQ40971398-4BFCEE33-59E1-4ABF-94ED-9AC3B4E3A4CBQ41454716-9DE37436-6FB0-4F46-A71C-BDC897310EADQ42039758-C78F61AE-60AC-4152-A01C-420B10B3AC73Q42370342-8EF73AED-8974-4E35-BF19-13C5738374ECQ46045622-A79CA933-6E6D-422B-A649-D71D8C1F102CQ46249375-2868410E-725D-46F3-BF9A-048CC1A2F466Q47126156-7F12154D-A422-446B-9FB7-6D3982F794F7Q49979292-C4C7B9AA-4304-46D9-B291-3675C1B346DDQ50855550-5A7125F7-A2B8-4BA1-8EEE-10C3A3C21A2DQ51658335-06495474-2411-4B48-8D41-0AC13CE204C6Q51813147-51FDE709-97CE-4E7B-8B8D-95D3D11AA3CBQ52699094-F2662417-0DD4-4C90-B10D-64D640D7DF6EQ52722360-3BB9EA67-AD12-410F-9B2C-3CEA99C39F3FQ55068395-11EFD6C2-C201-423E-B84D-4743ABC8098EQ55384045-C3F9461B-5FE7-4940-A82C-F0DEC8BBD5A7
P2860
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@en
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@nl
type
label
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@en
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@nl
prefLabel
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@en
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@nl
P2093
P2860
P356
P1476
U6 is unsuitable for normaliza ...... with sepsis or liver fibrosis.
@en
P2093
Alexander Koch
Christian Trautwein
Christoph Roderburg
David Vargas Cardenas
Fabian Benz
Frank Tacke
Henning Zimmermann
Jérémie Gautheron
Jörn Janssen
Lukas Nieuwenhuijsen
P2860
P2888
P356
10.1038/EMM.2013.81
P577
2013-09-20T00:00:00Z